Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses.
about
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adultsSubcuticular sutures for skin closure in non-obstetric surgeryVortioxetine for depression in adultsPreoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgeryKetamine and other glutamate receptor modulators for depression in bipolar disorder in adultsKetamine and other glutamate receptor modulators for depression in adultsPsychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crisesAntidepressants and benzodiazepines for panic disorder in adultsAzapirones versus placebo for panic disorder in adultsPsychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adultsParoxetine versus other anti-depressive agents for depressionSupported employment for adults with severe mental illnessBupropion versus other antidepressive agents for depressionDuloxetine versus other anti-depressive agents for depressionPreoperative inspiratory muscle training for postoperative pulmonary complications in adult patients undergoing cardiac and major abdominal surgeryFluoxetine versus other types of pharmacotherapy for depressionBenzodiazepines versus placebo for panic disorder in adultsAntidepressants versus placebo for panic disorder in adultsCitalopram versus other anti-depressive agents for depressionTiagabine for acute affective episodes in bipolar disorderCollaborative care approaches for people with severe mental illnessAzapirones versus placebo for panic disorder in adultsValproic acid, valproate and divalproex in the maintenance treatment of bipolar disorderCollaborative care approaches for people with severe mental illnessMirtazapine versus other antidepressive agents for depressionOxcarbazepine for acute affective episodes in bipolar disorderTiagabine in the maintenance treatment of bipolar disorderModafinil for schizophreniaSertraline versus other antidepressive agents for depressionFluvoxamine versus other anti-depressive agents for depressionMilnacipran versus other antidepressive agents for depressionReboxetine versus other antidepressive agents for depressionCombined psychotherapy plus benzodiazepines for panic disorderSertraline versus other antidepressive agents for depressionEscitalopram versus other antidepressive agents for depressionSupported employment for adults with severe mental illnessCombined psychotherapy plus antidepressants for panic disorder with or without agoraphobiaHydroxyzine for generalised anxiety disorderPsychotherapy for depression among incurable cancer patientsCombined psychotherapy plus benzodiazepines for panic disorder with or without agoraphobia
P2860
Q22252957-DDECC877-5D9C-4D54-B186-07921BECFA1EQ24186072-68BC6C90-1251-4581-B63C-73B6E73AB85EQ24186313-831675FD-C04E-4413-82AB-6B2E3B90D481Q24186626-6FE1DE51-8DBC-4679-9F2B-BD40B19A90BFQ24186726-EB59CCE3-FDEB-4ACB-9CDA-A3D2C7F70698Q24186746-A43436BD-CE03-4F5C-BC3B-B09424215B31Q24186781-3D39F9D3-92A4-4E6F-BB6C-4359AC8E773BQ24187763-5C28F890-2751-4C7F-8AD1-266B1590C130Q24193425-DEC64364-6D40-463A-9E71-BF97363FC4A8Q24195085-0DF7F5C7-9B9A-4121-B3F4-9E89443CC370Q24197507-01E07E1C-556F-422C-9EB5-2E9B88FBC094Q24198083-B624E147-7761-43FD-A39C-DCEC8F2FE4A7Q24198214-9FCCAB34-985C-4A85-AA97-07781466855BQ24198808-3CD8015B-512C-43F0-861A-DBE660BCF6FEQ24201154-E56B7F9A-3EB0-4331-B913-EDFB39F64BBAQ24201165-5A073082-0F8B-4953-BB12-5F815ED3387CQ24201464-1B084652-6998-4EC7-9F8D-7B7A4BDCFF26Q24201481-BF275A57-7AC5-4444-B8D8-66EC1A9CA9EBQ24202141-C7AC953C-800F-45CC-BB57-191B12B701E8Q24202532-AD6A90FC-EFEF-404E-8FB9-1CAD065FF27AQ24202558-26EA6155-0713-48AB-81D3-D452CE8EA0DDQ24202655-469DA76E-8510-45E8-B9CD-60384AF66637Q24203023-74FB79F2-54C3-408D-A30C-7AC610CABD70Q24203981-A32E7014-AA2F-405D-8951-092EA7C6E015Q24234046-D14667A2-4DAC-48E1-8DF5-4EFB75826E33Q24234152-5FFE0481-D627-4385-86BD-4834B1E6111BQ24234313-B880DAF7-F785-4F91-BF62-CCB7F9189C0BQ24235809-03F0FD09-3E93-4722-BC5D-CE979D50FF65Q24235928-C614403B-B6A4-4DDB-A6F8-FFC60CF8C9ADQ24236814-A41C0766-43EE-4736-ADE7-35C9D2E132BDQ24240125-1E0AF22E-B27F-4B3A-944F-D4D853330A80Q24240504-B1F18F17-9767-4046-B5D2-131C6D8DC28FQ24240927-A5FA70B9-1A16-48E2-870B-FCA7B96C3213Q24241023-4D558394-CB92-490B-A9DF-72582A4F9915Q24241065-323EDC9C-A424-4822-A763-46089DD9FA6DQ24241444-AE60E604-3176-470B-99FC-0AF211FBA599Q24243197-DD83F447-B184-403D-A5A1-2B5D51EDB8A5Q24243207-4F37A52F-4412-4EA7-A44B-A3BF629E6A39Q24243311-3D270D9F-C443-463F-8B89-C4D50E111EA2Q24245261-B1B5F932-371C-4634-B0BC-5F2E3CE68147
P2860
Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Can we individualize the 'numb ...... ect measures in meta-analyses.
@ast
Can we individualize the 'numb ...... ect measures in meta-analyses.
@en
type
label
Can we individualize the 'numb ...... ect measures in meta-analyses.
@ast
Can we individualize the 'numb ...... ect measures in meta-analyses.
@en
prefLabel
Can we individualize the 'numb ...... ect measures in meta-analyses.
@ast
Can we individualize the 'numb ...... ect measures in meta-analyses.
@en
P2860
P356
P1476
Can we individualize the 'numb ...... ect measures in meta-analyses.
@en
P2093
Lauren E Griffith
Toshiaki A Furukawa
P2860
P356
10.1093/IJE/31.1.72
P577
2002-02-01T00:00:00Z